Suratwwala Business Group develops commercial and residential real estate projects in the Pune region and operates a subsidiary focused on solar power installation and energy sales.
The company lacks a durable moat as evidenced by a sharp decline in revenue and earnings in FY25 despite claims of 'exceptional performance.' While they have a localized land bank, the business is highly cyclical with no clear pricing power or cost advantage that protects margins during market downturns.
Management has shifted focus toward an asset-light model while simultaneously increasing long-term debt significantly in FY25 to acquire new commercial assets. They are also diversifying into solar energy, which now contributes over 10% of revenue but represents a departure from their core real estate competency.
The investment collapsed as the company's pivot to an asset-light model failed to offset the burden of its massive debt spike. The diversification into solar energy proved to be a capital-intensive distraction that diluted management's focus on the core real estate business. As the localized land bank was depleted, the lack of a genuine moat became apparent; the company could not maintain margins against larger competitors, and the negative cash conversion cycle eventually led to a liquidity crisis that forced fire sales of assets.
RichFakir rates Suratwwala Business Group Ltd's business quality as poor — 52/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Suratwwala Business Group Ltd is trading about 5% above our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Suratwwala Business Group Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Suratwwala Business Group Ltd's fair value is about ₹19 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →